Employment Verification for Sarepta Therapeutics.

About Sarepta Therapeutics

Sarepta Therapeutics is a biopharmaceutical company that mainly focuses on the development of innovative RNA-targeted therapeutics. The company was established in 1980 and is headquartered in Cambridge, Massachusetts. At present, Sarepta Therapeutics has a team of experienced professionals who are dedicated to carrying out extensive research to develop therapies aimed at improving the lives of patients with rare diseases. Sarepta Therapeutics’ product pipeline focuses on RNA-based therapeutics mainly aimed at Duchenne muscular dystrophy (DMD), Limb-girdle muscular dystrophy (LGMD), and other diseases caused by genetic mutations. The company’s first product, EXONDYS 51 (eteplirsen), received FDA approval in 2016 for the treatment of DMD. The company has also initiated various clinical trials for Eteplirsen and myostatin inhibitor SRK-015. In addition to its internal product developments, Sarepta Therapeutics has entered into numerous collaborations with other biopharmaceutical companies to achieve its objectives. The company has a mission of improving the lives of those affected by rare diseases, and it’s rapidly growing with its innovative approach to drug development and scientific discoveries.

The information on this page is not an endorsement of Truv’s services by Sarepta Therapeutics and is meant to be purely informational.

Verify Sarepta Therapeutics Employees

Truv provides quick, secure and cost-effective employment and income verifications for thousands of verifiers. The process is simple and automated and most employees are verified in under 24 hours. You only pay for successful verification and can save on average 50% compared to competitors. Thousands of verifiers love Truv because it’s been never been easier and more streamlined to verify an employee, learn more.